Wegovy (semaglutide) is a prescription-only medicine licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities. Many patients ask: can you buy Wegovy online in the UK? The answer is yes, but only through registered online pharmacies and telehealth services that comply with strict regulatory standards. Purchasing Wegovy requires a valid prescription following a legitimate medical consultation with a GMC-registered doctor, NMC-registered nurse prescriber, or GPhC-registered pharmacist prescriber. This article explains how to purchase Wegovy safely online, what clinical criteria you must meet, and how to identify legitimate providers whilst avoiding unregulated sellers and counterfeit products.

Is Wegovy Available to Buy Online in the UK?

Yes, Wegovy (semaglutide) can be purchased online in the UK through registered online pharmacies and telehealth services, provided you meet the clinical eligibility criteria and complete a legitimate medical consultation. Wegovy is a prescription-only medicine (POM) licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for chronic weight management in adults with obesity or overweight with weight-related comorbidities.

It is illegal and unsafe to purchase Wegovy without a valid prescription from an appropriately registered healthcare professional. The General Pharmaceutical Council (GPhC) regulates online pharmacies in the UK, and legitimate services must display the GPhC distance selling logo (UK) and their GPhC registration number on their websites. Online prescribing services must also be registered with the Care Quality Commission (CQC). These safeguards ensure that medicines are genuine, stored correctly, and dispensed following a proper clinical assessment.

Wegovy is not available over the counter in high-street pharmacies or supermarkets. All purchases require a prescription issued following a consultation with a GMC-registered doctor, NMC-registered nurse prescriber, or GPhC-registered pharmacist prescriber. Many online services offer remote consultations via questionnaires, video calls, or asynchronous messaging, which must meet the same clinical standards as face-to-face appointments.

Wegovy is administered as a weekly subcutaneous injection, with doses titrated from 0.25 mg up to a maintenance dose of 2.4 mg according to the product's Summary of Product Characteristics (SmPC).

Supply of Wegovy has been subject to intermittent shortages in the UK and globally since its launch. The Department of Health and Social Care (DHSC) and NHS England have issued guidance prioritising existing patients and those at highest clinical need. Before attempting to purchase Wegovy online, check current supply status and ensure the provider can guarantee continuity of treatment, as interruptions may affect weight management outcomes and increase the risk of adverse effects upon restarting.

What to Know Before Buying Wegovy Online

Clinical eligibility for Wegovy is defined by the MHRA marketing authorisation and NICE technology appraisal guidance (TA875). It is indicated for adults with a body mass index (BMI) of ≥30 kg/m² (obesity), or ≥27 kg/m² (overweight) in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease. Wegovy should be used alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management programme.

Important contraindications and cautions must be assessed before prescribing. According to the UK SmPC, Wegovy is contraindicated in patients with hypersensitivity to semaglutide or any of the excipients. Caution is required in patients with diabetic retinopathy, severe gastrointestinal disease, renal impairment, or a history of pancreatitis. Wegovy should not be used during pregnancy or breastfeeding, and should be discontinued at least 2 months before a planned pregnancy. Effective contraception is advised for women of childbearing potential while using Wegovy.

Wegovy should not be used in combination with other GLP-1 receptor agonists or other semaglutide products (such as Ozempic or Rybelsus).

Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain, particularly during dose escalation. These gastrointestinal symptoms are usually transient and improve with continued use. Serious but rare adverse effects include pancreatitis, gallbladder disease, acute kidney injury (secondary to dehydration), and hypoglycaemia (especially in patients taking concomitant antidiabetic medications). Patients should be monitored for changes in mood or suicidal thoughts and seek prompt medical advice if these occur.

Before purchasing online, ensure you have had recent measurements of weight, height, blood pressure, and relevant blood tests as appropriate to your medical history to inform prescribing decisions. A legitimate online service will request this information and may decline to prescribe if clinical criteria are not met or if further investigation is needed. Never purchase Wegovy from unregulated websites, social media sellers, or overseas suppliers offering the medicine without prescription, as these products may be counterfeit, contaminated, or incorrectly stored.

Where to Buy Wegovy Online Safely

When seeking to purchase Wegovy online, it's essential to use only regulated online pharmacy and prescribing services. Legitimate providers should be registered with both the General Pharmaceutical Council (GPhC) and the Care Quality Commission (CQC) for prescribing services. You can verify these registrations on their respective public registers.

A proper online consultation process should include assessment of:

• Medical history – including cardiovascular disease, diabetes, thyroid disorders, gastrointestinal conditions, and psychiatric history

• Current medications – to identify potential drug interactions or contraindications

• Weight management history – previous attempts at diet, exercise, and pharmacological or surgical interventions

• Realistic expectations – understanding that Wegovy is an adjunct to lifestyle modification, not a standalone solution

Reputable online providers should supply patient information leaflets, injection technique guidance, and advice on managing side effects. Patients should receive follow-up consultations every 4–12 weeks to monitor weight loss, tolerability, and adherence. According to the Wegovy SmPC, treatment should be discontinued if patients have not lost at least 5% of their initial body weight after 12 weeks on the maintenance dose of 2.4 mg.

Pricing transparency is an important feature of reputable online providers. Wegovy is available on NHS prescription only within specialist weight management services for patients meeting NICE TA875 criteria, with a maximum treatment duration of 2 years. Most patients will pay privately. Costs typically range from £150–£250 per month depending on dose and provider. Legitimate services should clearly itemise consultation fees, medication costs, and delivery charges upfront, with no hidden fees.

Continuity of care is critical. Ensure the provider can supply Wegovy consistently over the intended treatment duration. Interruptions in supply can lead to loss of therapeutic effect and recurrence of side effects upon restarting. Check that the provider has clear protocols for managing side effects and emergency situations.

Other Reputable Online Providers Offering Wegovy

Several GPhC-registered online pharmacies and CQC-registered telehealth platforms offer Wegovy in the UK, each with slightly different service models, pricing, and support structures. When choosing a provider, verify GPhC and CQC registration, read patient reviews, and compare consultation processes and ongoing care provisions. The inclusion of specific providers below is for information only and does not constitute an endorsement.

Some online pharmacies offer Wegovy through asynchronous online consultations reviewed by GMC-registered doctors. These services may include weight tracking tools, lifestyle advice, and regular follow-up questionnaires. Some high-street pharmacy chains also provide online prescribing services with the option for in-person consultations in selected stores, which may be preferable for patients who value face-to-face interaction.

Other providers offer Wegovy through video or questionnaire-based consultations. These services may provide comprehensive patient resources, including dietary and exercise guidance, and may have networks of in-store pharmacists available for additional support. Some include regular weight and health monitoring as part of the treatment package.

Digital-first weight management platforms may offer Wegovy alongside structured lifestyle coaching, app-based tracking, and access to dietitians or health coaches. These services may suit patients seeking more intensive behavioural support alongside pharmacotherapy.

Key safety checks when selecting any provider:

• GPhC registration – verify the registration number on the GPhC website

• CQC registration – check the CQC register for online prescribing services

• Prescriber credentials – ensure consultations are conducted by GMC-registered doctors, NMC-registered nurse prescribers, or GPhC-registered pharmacist prescribers

• Transparent pricing – clear breakdown of all costs with no hidden fees

• Clinical governance – evidence of protocols for monitoring, follow-up, and managing adverse effects

• Patient support – access to prescribers or pharmacists for questions and concerns

Avoid unregulated sellers advertising Wegovy on social media, auction sites, or websites without clear regulatory credentials. Also avoid 'compounded' semaglutide or 'research' products that are not licensed medicines. Counterfeit semaglutide products have been identified globally, some containing incorrect doses, no active ingredient, or harmful contaminants.

If you experience severe or persistent abdominal pain, symptoms of gallbladder disease, or any unexpected side effects, stop using the medicine and seek urgent medical advice via NHS 111 or an urgent care service. Report suspected side effects or counterfeit products to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions